Joseph Tartaglia is a Cardiology physician affiliated with New York Medical College. OpenAlex indexes 10 publications with 233 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
311 North St
Suite 402
White Plains, NY 106052217
Telephone
914-946-3388Registry record last updated 14 Jan 2011.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
- Boston Scientific CorporationProgram year20253 payments
- BridgeBio Pharma, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.8%Beta blocker22.4%Carvedilol33%Metoprolol Succinate22%Atenolol22%Nebivolol Hcl11%Metoprolol Tartrate8%Propranolol Hcl2%Propranolol Hcl Er2%Part D<11 patientsStatin16.3%Atorvastatin Calcium65%Rosuvastatin Calcium30%Pravastatin Sodium5%Part D<11 patients+ 14 more classes in this area
Blood & clotting
11.9%Factor Xa inhibitor7.5%Eliquis55%Xarelto45%Part D≥34 patientsP2Y12 inhibitor2%Clopidogrel100%Part D≥19 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1.7%SGLT2 inhibitor1.3%Jardiance60%Inpefa40%Part D<11 patientsBiguanide (metformin)0.3%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mobilization of Endogenous CD34+/CD133+ Endothelial Progenitor Cells by Enhanced External Counter Pulsation for Treatment of Refractory Angina
International Journal of Molecular Sciences
2024 - Direct current cardioversion-triggered atypical Tako-tsubo cardiomyopathy: a case report and review of literature
European Heart Journal - Case Reports
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mitchell Cairo, MD
New York Medical College
Leslie Citrome, MD, MPH
New York Medical College
Jerry Nadler
New York Medical College
Karen Seiter, MD
New York Medical College
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”